Detalhe da pesquisa
1.
Lineage-specific detection of residual disease predicts relapse in patients with chronic myeloid leukemia stopping therapy.
Blood
; 142(25): 2192-2197, 2023 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37616555
2.
Immune modulation in chronic myeloid leukaemia patients treated with nilotinib and interferon-alpha.
Br J Haematol
; 202(6): 1127-1136, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37482935
3.
Solute Carrier Family 29A1 Mediates In Vitro Resistance to Azacitidine in Acute Myeloid Leukemia Cell Lines.
Int J Mol Sci
; 24(4)2023 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36834962
4.
Outcomes following venetoclax-based treatment in therapy-related myeloid neoplasms.
Am J Hematol
; 97(8): 1013-1022, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35560061
5.
Successful treatment-free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cells.
Br J Haematol
; 191(3): 433-441, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32352166
6.
TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype.
Blood
; 141(9): 1087-1091, 2023 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36574363
7.
Pre-B acute lymphoblastic leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct gene expression.
Br J Cancer
; 118(7): 1000-1004, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29531323
8.
Increased peroxisome proliferator-activated receptor γ activity reduces imatinib uptake and efficacy in chronic myeloid leukemia mononuclear cells.
Haematologica
; 102(5): 843-853, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28154092
9.
Ecotopic viral integration site 1 (EVI1) regulates multiple cellular processes important for cancer and is a synergistic partner for FOS protein in invasive tumors.
Proc Natl Acad Sci U S A
; 109(6): 2168-73, 2012 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-22308434
10.
The GM-CSF receptor utilizes ß-catenin and Tcf4 to specify macrophage lineage differentiation.
Differentiation
; 83(1): 47-59, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22099176
11.
The acquisition order of leukemic drug resistance mutations is directed by the selective fitness associated with each resistance mechanism.
Sci Rep
; 13(1): 13110, 2023 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37567965
12.
Adverse outcomes for chronic myeloid leukemia patients with splenomegaly and low in vivo kinase inhibition on imatinib.
Blood Cancer J
; 13(1): 143, 2023 09 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37696829
13.
Association of TIM-3 checkpoint receptor expression on T cells with treatment-free remission in chronic myeloid leukemia.
Blood Adv
; 7(11): 2364-2374, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36622326
14.
Factors predicting survival following alloSCT in patients with therapy-related AML and MDS: a multicenter study.
Bone Marrow Transplant
; 58(7): 769-776, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37012415
15.
A Personalized Risk Model for Azacitidine Outcome in Myelodysplastic Syndrome and Other Myeloid Neoplasms Identified by Machine Learning Model Utilizing Real-World Data.
Cancers (Basel)
; 15(16)2023 Aug 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37627047
16.
High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment.
Haematologica
; 102(12): e490-e493, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28935844
17.
RNA-Based Targeted Gene Sequencing Improves the Diagnostic Yield of Mutant Detection in Chronic Myeloid Leukemia.
J Mol Diagn
; 24(7): 803-822, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35550185
18.
Expression profiling of a hemopoietic cell survival transcriptome implicates osteopontin as a functional prognostic factor in AML.
Blood
; 114(23): 4859-70, 2009 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-19805619
19.
Polycomb Factor PHF19 Controls Cell Growth and Differentiation Toward Erythroid Pathway in Chronic Myeloid Leukemia Cells.
Front Cell Dev Biol
; 9: 655201, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33996816
20.
Integrated Bioinformatics Analysis Reveals Key Candidate Genes and Pathways Associated With Clinical Outcome in Hepatocellular Carcinoma.
Front Genet
; 11: 814, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32849813